Table 5.
Association between change in physical activity status and duration of general and symptoms specific long COVID in adults (N = 237).
Outcome | Persisted inactive | Became inactive |
Became active |
Persisted active |
---|---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | ||
Long COVID | Ref | 0.76 (0.42, 1.37) | 0.58 (0.23, 1.49) | 0.33 (0.17,0.64) |
P-value | 0.364 | 0.227 | 0.001 | |
Symptom-specific long COVID | ||||
Fatigue | Ref | 0.42 (0.23, 0.78) | 0.68 (0.24, 1.88) | 0.20 (0.09, 0.41) |
P-value | 0.025 | 0.494 | <0.001 | |
Neurological complications | Ref | 0.60 (0.32, 1.12) | 0.21 (0.05, 0.79) | 0.26 (0.12, 0.58) |
P-value | 0.110 | 0.016 | 0.002 | |
Cough | Ref | 1.01 (0.53, 1.92) | 1.18 (0.41, 3.43) | 0.23 (0.10, 0.53) |
P-value | 0.953 | 0.799 | 0.001 | |
Loss of sense of smell or taste | Ref | 0.72 (0.36, 1.43) | 0.98 (0.31, 3.09) | 0.30 (0.13, 0.75) |
P-value | 0.313 | 0.882 | 0.009 | |
Headache | Ref | 0.45 (0.23, 0.88) | 1.14 (0.39, 3.30) | 0.28 (0.12, 0.64) |
P-value | 0.022 | 0.836 | 0.003 |
CI: confidence interval; OR, odds ratio.
OR >1 indicates higher odds for persistent symptoms lasting longer.
General long COVID was defined as any post-COVID-19 symptoms that persisted for at least 3 months.
Symptom-specific long COVID were based on individual symptoms.
Physical activity before the pandemic was assessed retrospectively during wave 1 (June 2020).
Physical activity during the pandemic was assessed during wave 1 (June 2020).
OR were estimated using proportional ordinal logistical regression models adjusted for age, sex, education, skin color, income, presence of comorbidities, and vaccination status.